¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"visual disorder"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • circadian rhythm sleep disorder
    ÇÏ·çÁÖ±âÀ²µ¿¼ö¸éÀå¾Ö, ÀÏÁÖ±âÀ²µ¿¼ö¸éÀå¾Ö
  • coagulation disorder
    ÀÀ°íÀå¾Ö
  • cognitive disorder
    ÀÎÁöÀå¾Ö
  • communication disorder
    ÀÇ»ç¼ÒÅëÀå¾Ö
  • compulsive personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • conduct disorder
    ÇൿÀå¾Ö
  • conversion disorder
    ÀüȯÀå¾Ö
  • coordination disorder
    Çùµ¿Àå¾Ö
  • cumulative trauma disorder
    ´©Àû¿Ü»óÀå¾Ö
  • cyclothymic disorder
    ¼øÈ¯±âºÐÀå¾Ö
  • central auditory processing disorder
    ÁßÃßû°¢Ã³¸®Àå¾Ö
  • childhood anxiety disorder
    ¼Ò¾ÆºÒ¾ÈÀå¾Ö
  • chromosomal disorder
    ¿°»öüÀå¾Ö
  • chronic myeloproliferative disorder
    ¸¸¼º°ñ¼öÁõ½ÄÁúȯ
  • dysthymic disorder
    ±âºÐÀúÇÏÀå¾Ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • circadian rhythm sleep disorder
    ÀÏÁÖ±âÀ²µ¿¼ö¸éÀå¾Ö, ÇÏ·çÁÖ±â¼ö¸éÀå¾Ö
  • coagulation disorder
    ÀÀ°íÀå¾Ö
  • cognitive disorder
    ÀÎÁöÀå¾Ö
  • communication disorder
    ÀÇ»ç¼ÒÅëÀå¾Ö
  • compulsive personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • conduct disorder
    Çà½ÇÀå¾Ö, Çà½Çº´
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • conversion voice disorder
    ÀüȯÀ½¼ºÀå¾Ö
  • coordination disorder
    ÇùÀÀÀå¾Ö
  • cutaneous disorder
    ÇǺÎÁúȯ
  • cyclothymic disorder
    ¼øÈ¯¼º±âºÐÀå¾Ö
  • disorder
    Àå¾Ö, Áúȯ
  • delusional disorder
    ¸Á»óÀå¾Ö
  • demyelinating disorder
    ¸»ÀÌÁýÅ»¶ôÁúȯ
  • dependent personality disorder
    ÀÇÁ¸ÀΰÝÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • personality disorder, psychopathic
    Á¤½Åº´Áú(ïñãêÜ»òõ)¼º ÀΰÝÀå¾Ö
  • personality disorder, schizoid
    ºÐ¿­¼º(ÝÂæñàõ) ÀΰÝÀå¾Ö
  • personality disorder, schizotypal
    ºÐ¿­Çü ÀΰÝÀå¾Ö
  • personality disorder, self- defeating
    ÀÚ±âÆÐ¹è¼º(í»Ðùø¨ÛÅàõ) ÀΰÝÀå¾Ö
  • personality disorder, sociopathic
    »çȸº´Áú¼º(ÞäüåÜ»òõàõ) ÀΰÝÀå¾Ö
  • pervasive developmental disorder
    Àü¹ÝÀû ¹ß´ÞÀå¾Ö(îïÚõîÜÛ¡Ó¹î¡äô)
  • phencyclidine use disorder
    Ææ½ÎÀÌŬ¸®µò »ç¿ëÀå¾Ö(º´)
  • phobic anxiety disorder
    °øÆ÷ºÒ¾ÈÀå¾Ö, ~º´
  • phobic disorder
    °øÆ÷Àå¾Ö,°øÆ÷º´
  • phonation disorder
    ¹ß¼ºÀå¾Ö
  • phonological disorder
    À½¼ºÇÐÀû Àå¾Ö, ~ º´
  • physiological disorder
    »ý¸® Àå¾Ö
  • platelet disorder
    Ç÷¼ÒÆÇÁúȯ
  • polysubstance-related disorder
    º¹ÇÕ¹°Áú°ü·ÃÀå¾Ö(º´)
  • porphyrin metabolic disorder
    Æ÷¸£ÇǸ°´ë»çÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • visual infancy
    ¿µ¾ÆÇü½Ã°¢
  • visual line
    ½Ã¼±(ãÊàÊ).
  • visual loss
    ½Ã°¢»ó½Ç, ½Ç¸í
  • visual maturity
    ¼ºÀÎÇü½Ã°¢
  • visual measurement
    ¸ñÃø(ÙÍö´).
  • visual memory
    ½Ã°¢±â¾ï(ãÊÊÆÑÀåã).
  • visual memory test
    ½Ã°¢±â¾ï°Ë»ç(~ËþÞÛ).
  • visual method
    À°¾È¹ý(ë¿äÑÛö), ½Ã°¢¹ý (ãÊÊÆÛö).
  • visual myoclonus
    ½Ã°¢¼º ±Ù°æ·Ã.
  • visual myoclonus
    ½Ã°¢¼º ±Ù°æ·Ã
  • visual neglect
    ½Ã°¢¹«½Ã(~ÙíãÊ)
  • visual nystagmus
    ½Ã°¢¼º¾ÈÁø
  • visual orange
    ½Ãµî
  • visual organ
    ½Ã°¢±â(ãÊÊÆÐï).
  • visual organ
    ½Ã°¢±â°ü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
EVP episcleral venous pressure; evoked visual potential
EVR evoked visual response; exudative vitreoretinopathy
GVF good visual fields
LVF left ventricular failure; left ventricular function; left visual field; low-voltage fast; low-voltag...
MVPT Motor-Free Visual Perception Test
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
VLAP Visual Laser Ablation of the Prostate
VMI Visual Motor Integration
VRA Visual Reinforcement Audiometry
VA Visual acuity
VAS Visual analog pain scale
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • language disorder
    ¾ð¾î Àå¾Ö
    ¸»À» ¹Ù¸£°Ô ¹ßÀ½ÇÏÁö ¸øÇϰųª Á¤È®ÇÏ°Ô ÀÌÇØÇÏÁö ¸øÇÏ´Â »óÅÂ. Àΰ£Àº ¸»
  • late luteal phase dysphoric disorder
    ¸»±â Ȳü±â ºÒÄè Àå¾Ö
  • major depressive disorder
    ÁÖ¿ä ¿ì¿ïÁõ
  • masticatory muscle pain disorder
    ÀúÀÛ±Ù µ¿Åë Àå¾Ö
  • menopausal disorder
    °»³â±â Àå¾Ö
    °»³â±â¿¡ »ý±â´Â ÀÚÀ²½Å°æ ½ÇÁ¶Áõ. ³­¼ÒÀÇ ³»ºÐºñ ±â´ÉÀÇ °¨Å𳪠ÆóÀýÀÌ ÁÖµÈ ¿øÀÎÀ̸ç, ¶ÇÇÑ °¢Á¾ÀÇ ³»ºÐºñ¼±, ƯÈ÷ ³úÇϼöü Àü¿±, °©»ó¼±, ºÎ½Å ¶Ç´Â ÃéÀå µîÀÇ ±â´ÉÀå¾Ö·Î ±×µé »óÈ£°£ÀÇ ÆòÇü ½ÇÁ¶¸¦ °¡Á®¿À°í, ³¡³»´Â ³»ºÐºñ Àå±â¸¦ Áö¹èÇÏ´Â ÀÚÀ²½Å°æ °èÅë¿¡ ¿µÇâÀ» ³¢ÃÄ ±³°¨½Å°æ ¶Ç´Â ºÎ±³°¨½Å°æ¿¡ ±äÀåÀ» ÃÊ·¡Çϱ⠶§¹®À̶ó°í ¿©°ÜÁö°í ÀÖ´Ù. Áõ¼¼¿¡´Â ±¹ºÎÀû Áõ¼¼¿Í Àü½Å Áõ¼¼°¡ ÀÖ´Ù. ±¹ºÎÀûÀÎ Áõ¼¼·Î´Â ³»¿Ü ¼º±âÀÇ À§ÃàÀÌ ÁÖµÈ Áõ»óÀÌ´Ù. ¿Ü¼º±âÀÎ ´ë, ¼ÒÀ½¼øÀº Áö¹æÀÇ ¼Ò½Ç·Î À§ÃàµÇ°í, À½¸ð´Â ¹«»öÀÌ µÈ´Ù. ³»¼º±â¿¡¼­´Â Áú º®ÀÌ ÆòÆòÇØÁö°í Áú °­Àº Á¼¾ÆÁö´Âµ¥, ¶§·Î´Â Áú¿° ¶§¹®¿¡ Áú °­ÀÌ À¯ÂøµÈ´Ù. ÀÚ±ÃÀº ±Ù¼¶À¯ÀÇ À§ÃàÀ¸·Î ÀüüÀûÀ¸·Î Âɱ׶óµé¸ç, °æ°ü ¹× ³» Àڱà ±¸´Â ¸Å¿ì Á¼¾ÆÁ®¼­ ¶§·Î´Â Æó¼âµÇ¾î À¯¼öÁ¾ ¶Ç´Â À¯³óÁ¾ÀÌ »ý±æ ¶§µµ ÀÖ´Ù. ³­¼Ò´Â ÀÛ¾ÆÁö°í ±â´Éµµ °¨ÅðÇÏ¿© ƯÀ¯ÀÇ ³­¼Ò ÁÖ±âÀÇ ºÒ±ÔĢȭ¿¡ µû¶ó ¿ù°æ ºÒ¼øÀ» ÀÏÀ¸Å°¸ç ¿ÏÀü Æó°æ¿¡ À̸¥´Ù. ³­°ü, Àڱà Àδë, º¹¸· µîµµ À§ÃàÇÑ´Ù. Á¦2Â÷ ¼ºÂ¡À¸·Î À¯¹æ°ú Àü½Å¿¡ °ÉÃÄ ÇÇÇÏ Áö¹æ Á¶Á÷ÀÇ ¼Ò½ÇÀÌ ÀϾ ¿©¼º´Ù¿î ¸ö¸Å¸¦ ÀÒ°Ô µÇ°í, ½ÉÁö¾î´Â ÀÔ°¡¿¡ ¼ö¿°ÀÌ ³ª´Â µî ³²¼ºÀûÀ¸·Î º¯¸ðÇÏ´Â °æ¿ìµµ ÀÖ´Ù. Àü½ÅÀÇ Áõ¼¼·Î´Â Ç÷°ü ¿îµ¿ ½Å°æ Àå¾Ö¿Í ÀÚÀ²½Å°æÁõÀÎ ¿­°¨, ³ÃÁõ, ÈïºÐ°¨, ½É°è Ç×Áø, ºÎÁ¤¸Æ, ºÎÁ¾ µîÀÌ ÀÖ´Ù. Á¤½Å ½Å°æ Àå¾Ö·Î´Â µÎÅë, µÎÁß°¨, Çö±âÁõ, ºÒ¸éÁõ, À̸íÁõ, ¿ì¿ïÁõ
  • metabolism disorder
    ´ë»ç Àå¾Ö
  • monopolar disorder
    ´Ü±Ø¼º Àå¾Ö
  • mood disorder
    ±âºÐ Àå¾Ö
  • motor output disorder
    ¿îµ¿¼º Ãâ·Â Àå¾Ö
  • motor skills disorder
    ¿îµ¿ ´É·Â Àå¾Ö
  • multisystem disorder
    ´Ù¹ßÀû Àü½Å ÀÌ»ó
  • muscle disorder
    ±ÙÀ° Àå¾Ö, ±Ù Àå¾Ö
  • muscle origin disorder
    ±ÙÀ°¼º Àå¾Ö
  • muscular disorder
    ±ÙÀ° Àå¾Ö
  • musculoskeletal pain disorder
    ±Ù °ñ°Ý¼º µ¿Åë Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
pervasive development disorder <neurology, psychiatry> A large group of developmental disabilities which are neurological disorders, usually of unknown cause.
Characteristics include reduced abilities to understand language and communicate normally, reduced ability to socially interact with others in a normal manner, and limited variety in activities and interests. Individuals will also often respond in unusual ways to sensations, engage in repetitive activities, and resist changes to the environment or to daily routines.
Types of pervasive development disorder include autism, Retts Syndrome, Hellers Syndrome, and Aspergers Syndrome.
Acronym: PDD
(12 Jan 1998)
chromosome disorder An abnormal condition due to an abnormality of the chromosomes. For example, Down syndrome (the genetic abnormality featuring three chromosome 21s, instead of two, also refered to as trisomy 21) is a chromosome disorder.
(12 Dec 1998)
rumination disorder A mental disorder occurring in infancy characterised by repeated regurgitation of food; usually accompanied by weight loss or failure to gain weight.
(05 Mar 2000)
cocaine-related disorder <psychiatry> Disorders related or resulting from use of cocaine.
(12 Dec 1998)
cognition disorder <psychology> Disturbances in the mental process related to thinking, reasoning, and judgment.
(12 Dec 1998)
compulsive personality disorder <psychology> A personality disorder which is characterised by the avoidance of feelings, emotion and intimacy within a framework of strict adherence to rules and order.
(05 Jan 1998)
conduct disorder A repetitive and persistent pattern of behaviour in which the basic rights of others or major age-appropriate societal norms or rules are violated. These behaviours include aggressive conduct that causes or threatens physical harm to other people or animals, nonagressive conduct that causes property loss or damage, deceitfulness or theft, and serious violations of rules. The onset is before age 18.
(12 Dec 1998)
multiple personality disorder A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behaviour patterns and social friendships. Transition from one personality to another is sudden.
(12 Dec 1998)
conversion disorder A disorder whose predominant feature is a loss or alteration in physical functioning that suggests a physical disorder but that is actually a direct expression of a psychological conflict or need.
(12 Dec 1998)
polygenic disorder <genetics> Genetic disorders resulting from the combined action of alleles of more thanone gene (for example, heart disease, diabetes, and some cancers). Although such disorders are inherited, they depend on the simultaneous presence of several alleles, thus the hereditary patterns are usually more complex than those of single-gene disorders.
(14 Oct 1997)
posttraumatic stress disorder Development of characteristic symptoms following a psychologically traumatic event that is generally outside the range of usual human experience; symptoms include numbed responsiveness to environmental stimuli, a variety of autonomic and cognitive dysfunctions, and dysphoria.
(05 Mar 2000)
cyclothymic disorder An affective disorder characterised by periods of depression and hypomania. These may be separated by periods of normal mood.
(12 Dec 1998)
cyclothymic personality disorder A personality disorder in which a person experiences regularly alternating periods of elation and depression, (see bipolar illness) usually not related to external circumstances or situation.
(27 Sep 1997)
Hartnup disorder <biochemistry> Amino acid transport defect that leads to excessive loss of monoamino monocarboxylic acids (cystine, lysine, ornithine, arginine) in the urine and poor absorption in the gut.
See: iminoglycinuria.
(18 Nov 1997)
heat stress disorder A group of conditions due to overexposure to or overexertion in excess environmental temperature.
It includes heat cramps, which are non-emergent and treated by salt replacement; heat exhaustion, which is more serious, treated with fluid and salt replacement; and heatstroke, a condition most commonly affecting extremes of age, especially the elderly, accompanied by convulsions, delusions, or coma and treated with cooling the body and replacement of fluids and salts.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á